Your search for major depressive disorder returned 66 results

Investigators conducted a systematic review of studies published between January 1, 2020 and January 29, 2021 that estimated the prevalence of major depressive disorder and anxiety disorders during the COVID-19 pandemic.

Patients who had treatment-naïve MDD were recruited in the US between 2007 and 2013 for the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study.

Investigators looked into which treatment fared better for patients with anxiety disorders: a mindfulness-based stress reduction intervention or escitalopram.

Researchers examined correlations between suicidal ideation and suicide attempt history in patients with treatment-resistant depression following ketamine infusion.

Looking at stress and university students during the COVID-19 pandemic.

To learn more about the impact of depression therapy on anxiety symptoms, researchers conducted a randomized controlled clinical trial with teenagers to compare the results of personalized depression therapy to a program that does not match their risk factors.

In addition to the physical risks, experts anticipate a myriad of mental health ramifications stemming from the loss of abortion access and the associated economic and occupational repercussions.

Researchers explored the neurobiology related to reward-based reinforcement learning and psychomotor retardation in patients in remission from MDD.

Data for this study were sourced from 4 active treatment arms of 4 randomized, controlled trials conducted by the National Institutes of Health in the United States between 2006 and 2018.

This retrospective cohort study evaluated patient data from patients aged 50 years or older who received an acute course of ECT between 2011 and 2019 and were evaluated for cognition and depression outcomes on the basis of baseline cognitive function.

With transgender and gender non-conforming individuals in China subject to minority stress and, as a result a higher risk of adverse mental health issues, researchers aimed to review the findings of the research on transgender and gender non-conforming individuals in that country. By doing so researchers hope to give an outlook to further research that can guide clinical practice and policy.

In a recent survey, more than half the college students with ADHD had at least 1 psychiatric disorder. The recent WHO World Mental Health Survey of college students assessed comorbidities in more than 15,000 college freshmen across 9 countries.

This systematic review and meta-analysis of randomized controlled trials assessed the efficacy and safety of gabapentin and duloxetine for treating patients with painful diabetic peripheral neuropathy.

The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to targeted areas of the brain.

Ensemble is an AI-powered digital mental health coach app designed to address the symptoms of MDD or GAD.

Patients with depression can live with symptoms for a long period of time before finding an option that works. One possibility for patients who are unable to find relief through pharmacology is transcranial magnetic stimulation. An expert offers his view on this form of treatment.

Major depressive episodes reduce visual contrast suppression among patients with depressive disorders, a study shows.

Psilocybin has been shown to have antidepressant properties. With direct comparisons between psilocybin and established treatments for depression lacking, the study researchers looked at psilocybin and escitalopram.

The researchers sought to estimate the age-specific incidence and prevalence of dementia diagnoses among older adults with schizophrenia in the United States compared to those without serious mental illness.

Researchers sought to evaluate the relationship among insomnia symptoms, inflammation, and risk for stroke.

Solanezumab is a humanized monoclonal antibody designed to increase clearance of soluble amyloid beta (Aβ) from the brain by binding to aggregated forms of Aβ.

Inpatients with schizophrenia spectrum disorders were randomly assigned to receive treatment as usual with or without a yoga-based group intervention for 4 weeks.

The REAL-ESK study was an observational, retrospective, multicenter study conducted in Italy.

Researchers sought to characterize real-world efficacy of repeated ketamine infusions for treatment-resistant bipolar depression assessing symptoms of depression, anxiety, suicidality, and functioning.

Investigators aimed to evaluate the efficacy of combined treatment (antidepressants plus STPP) vs antidepressants (with or without brief supportive psychotherapy) on depressive symptoms in adults in acute-phase depression.

Can reducing RNT with psychological treatment approaches help improve youth depression and anxiety?

Researchers investigated whether individuals with symptoms of depression were more sensitive to missed opportunities.

Researchers sought to investigate the associations between time perception, intensity of physical activity, impulsivity, anxiety and depressive symptoms, and the degree to which resting state motion intensity can be used to recognize anxiety and depressive symptoms.

Investigators sought to find out if the psychiatric effects of the COVID-19 pandemic were more strongly pronounced in individuals with lower economic and personal capital.

This observational study was conducted by telephone interviews between April and July 2020.